(Q45409580)

English

Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens

scientific article published on 17 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

0 references

Alexander K. Andrianov

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

8

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

George Mutwiri

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ponn Benjamin

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Henry Soita

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hugh Townsend

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Richard Yost

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Bryan Roberts

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

17 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1204-1213

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Recent advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Antigen delivery systems and immunostimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Mechanisms of stimulation of the immune response by aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Protein release from polyphosphazene matrices

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Recent developments in adjuvants for vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.011

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.10.011

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45409580&oldid=2076675243"